Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology’s ORA registry

Observational Cross-Sectional Study Revealing Less Aggressive Treatment in Japanese Elderly Than Nonelderly Patients With Rheumatoid Arthritis

(2015) Michihiro Ogasawara et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

(2014) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

(2014) Huifeng Yun et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Rituximab in Elderly Patients With Rheumatoid Arthritis Enrolled in a French Society of Rheumatology Registry

(2014) Sarah Payet et al.   ARTHRITIS CARE & RESEARCH

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor

(2013) Leslie R Harrold et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid Arthritis in the Elderly in the Era of Tight Control

(2013) Martin Soubrier et al.   DRUGS & AGING

Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

(2013) Eva Salgado et al.   JOINT BONE SPINE

Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program

(2013) M. E. Weinblatt et al.   JOURNAL OF RHEUMATOLOGY

Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis

(2013) R.J. Maneiro et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis

(2012) John D Isaacs et al.   ANNALS OF THE RHEUMATIC DISEASES

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

(2012) J E Gottenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

(2012) Lene Dreyer et al.   ANNALS OF THE RHEUMATIC DISEASES

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis

(2012) William G Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy

(2012) Maria A. Lopez-Olivo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy

(2012) MARK C. GENOVESE et al.   JOURNAL OF RHEUMATOLOGY

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

(2012) Jeffrey R. Curtis et al.   ARTHRITIS CARE & RESEARCH

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

(2011) K. Chatzidionysiou et al.   ANNALS OF THE RHEUMATIC DISEASES

TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis

(2011) Michael A. Lane et al.   MEDICINE

Prevention and treatment of systemic glucocorticoid side effects

(2010) Siamak Moghadam-Kia et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Elderly-onset rheumatoid arthritis

(2010) Martin Soubrier et al.   JOINT BONE SPINE

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

(2010) J. B. Galloway et al.   RHEUMATOLOGY

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

(2009) R Westhovens et al.   ANNALS OF THE RHEUMATIC DISEASES

Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis

(2007) B J Radovits et al.   ANNALS OF THE RHEUMATIC DISEASES